TY - JOUR
T1 - Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation
AU - for the Hi-CARAT investigators
AU - Yang, Yichi
AU - Kimura, Hirokazu
AU - Yokota, Isao
AU - Makita, Hironi
AU - Takimoto-Sato, Michiko
AU - Matsumoto-Sasaki, Machiko
AU - Matsumoto, Munehiro
AU - Oguma, Akira
AU - Abe, Yuki
AU - Takei, Nozomu
AU - Goudarzi, Houman
AU - Shimizu, Kaoruko
AU - Suzuki, Masaru
AU - Nishimura, Masaharu
AU - Konno, Satoshi
AU - Isada, Akira
AU - Hattori, Takeshi
AU - Shimizu, Kenichi
AU - Yoshida, Takayuki
AU - Nagaoka, Kentaro
AU - Nakane, Shinji
AU - Saito, Yoshiyuki
AU - Sasaki, Tsukasa
AU - Honda, Hideko
AU - Deai, Miho
AU - Muramoto, Ayako
AU - Kudo, Natsumi
AU - Sato, Nozomi
AU - Suzuki, Masanobu
AU - Saito, Hiroshi
AU - Kojima, Tetsuya
AU - Ichimura, Shiho
AU - Choji, Takashi
AU - Kobayashi, Motoko
AU - Ishikuro, Akihiko
AU - Ohtsuka, Yoshihiro
AU - Honmura, Fumihiro
AU - Akiyama, Yasushi
AU - Harada, Toshiyuki
AU - Kamimura, Akira
AU - Tashiro, Norio
AU - Mikami, Hiroshi
AU - Ohmichi, Mitsuhide
AU - Sugawara, Yoshitaka
AU - Takahashi, Toshiki
AU - Yamamoto, Makoto
AU - Takamura, Kei
AU - Tokuchi, Yoshio
AU - Inoue, Yuji
AU - Shigehara, Katsunori
N1 - Publisher Copyright:
© 2023 American College of Allergy, Asthma & Immunology
PY - 2024/4
Y1 - 2024/4
N2 - Background: Real-time asthma exacerbation prediction and acute asthma attack detection are essential for patients with severe asthma. Peak expiratory flow (PEF) exhibits a potential for use in long-term asthma self-monitoring. However, the method for processing PEF calculations remains to be clarified. Objective: To develop clinically applicable novel exacerbation predictors calculated using PEF records. Methods: Previously proposed exacerbation predictors, including the slope of PEF, percentage predicted PEF, percentage best PEF, the highest PEF over the lowest PEF within specific periods, and PEF coefficient of variation, in addition to a novel indicator delta PEF moving average (ΔMA), defined as the difference between 14-day and 3-day average PEF values, along with moving average (MA) adjusted for PEF reference (%ΔMA), were verified using the Hokkaido-based Investigative Cohort Analysis for Refractory Asthma data of 127 patients with severe asthma from whom 73,503 PEF observations were obtained. Receiver operating characteristic curves for all predictors were drawn, and the corresponding areas under the curve (AUCs) were computed. Regression analysis for MA and percentage MA were conducted. Results: The most outstanding performance was shown by ΔMA and %ΔMA, with AUC values of 0.659 and 0.665 in the univariate model, respectively. When multivariate models were incorporated with random intercepts for individual participants, the AUC for ΔMA and %ΔMA increased to 0.907 and 0.919, respectively. Conclusion: The MA and percentage MA are valuable indicators that should be considered when deriving predictors from the PEF trajectory for monitoring exacerbations in patients with severe asthma. Trial Registration: The Hokkaido-based Investigative Cohort Analysis for Refractory Asthma was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN ID: 000003254). https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003917
AB - Background: Real-time asthma exacerbation prediction and acute asthma attack detection are essential for patients with severe asthma. Peak expiratory flow (PEF) exhibits a potential for use in long-term asthma self-monitoring. However, the method for processing PEF calculations remains to be clarified. Objective: To develop clinically applicable novel exacerbation predictors calculated using PEF records. Methods: Previously proposed exacerbation predictors, including the slope of PEF, percentage predicted PEF, percentage best PEF, the highest PEF over the lowest PEF within specific periods, and PEF coefficient of variation, in addition to a novel indicator delta PEF moving average (ΔMA), defined as the difference between 14-day and 3-day average PEF values, along with moving average (MA) adjusted for PEF reference (%ΔMA), were verified using the Hokkaido-based Investigative Cohort Analysis for Refractory Asthma data of 127 patients with severe asthma from whom 73,503 PEF observations were obtained. Receiver operating characteristic curves for all predictors were drawn, and the corresponding areas under the curve (AUCs) were computed. Regression analysis for MA and percentage MA were conducted. Results: The most outstanding performance was shown by ΔMA and %ΔMA, with AUC values of 0.659 and 0.665 in the univariate model, respectively. When multivariate models were incorporated with random intercepts for individual participants, the AUC for ΔMA and %ΔMA increased to 0.907 and 0.919, respectively. Conclusion: The MA and percentage MA are valuable indicators that should be considered when deriving predictors from the PEF trajectory for monitoring exacerbations in patients with severe asthma. Trial Registration: The Hokkaido-based Investigative Cohort Analysis for Refractory Asthma was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN ID: 000003254). https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003917
UR - http://www.scopus.com/inward/record.url?scp=85180595118&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2023.11.015
DO - 10.1016/j.anai.2023.11.015
M3 - 学術論文
C2 - 38006971
AN - SCOPUS:85180595118
SN - 1081-1206
VL - 132
SP - 469
EP - 476
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 4
ER -